Moscow, Russia

Galina P Titova

This inventor holds 1 USPTO granted patent. Top assignee: Vsesojuzny Kardiologichesky Nauchny Tsentr Akademii Meditsinskikh Nauk. Active years: 1987.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Galina P Titova. Retrieved from https://idiyas.com/inventor/galina-p-titova

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 12.0

ph-index = 1


Company Filing History:


Years Active: 1987

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Galina P. Titova: A Pioneer in Peptide Innovation

Introduction

Galina P. Titova is an esteemed inventor based in Moscow, Russia. With a notable contribution to the field of biomedical science, Titova has made significant strides in peptide research, particularly with her groundbreaking invention related to hexapeptides.

Latest Patents

Galina P. Titova holds a patent for her innovative work on hexapeptides. This patent highlights her expertise and dedication to advancing medical science through the development of new compounds that could have important therapeutic applications.

Career Highlights

Galina is affiliated with the Vsesoyuzny Kardiologichesky Nauchny Tsentr Akademii Meditsinskikh Nauk, a leading research center in cardiology. Her role at this prestigious institution underscores her influence and commitment to advancing cardiovascular research and treatment.

Collaborations

Throughout her career, Galina has collaborated with notable colleagues such as Evgeny I. Chazov and Vladimir N. Smirnov. These partnerships reflect her engagement with other experts in the field, which enhances the impact of her research and inventions.

Conclusion

With her innovative contributions to peptide research and her collaboration with prominent scientists, Galina P. Titova stands out as a key figure in the biomedical field. Her work continues to inspire future discoveries and advancements, making her a valuable asset to the scientific community.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…